Influence of renal replacement therapy on outcome of patients with acute renal failure  by Kresse, Sven et al.
Kidney International, Vol. 56, Suppl. 72 (1999), pp. S-75–S-78
Influence of renal replacement therapy on outcome of patients
with acute renal failure
SVEN KRESSE, HENDRIK SCHLEE, HEINZ JU¨RGEN DEUBER, WOLFGANG KOALL,
and BERND OSTEN
Department of Nephrology, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany
Influence of renal replacement therapy on outcome of patients responsible for a minority of deaths, and patients die
with acute renal failure. There are many controversial results “with” and not “because of” ARF [5].
about the influence of acute renal failure (ARF) and renal Prerenal causes (for example, volume depletion, car-replacement therapy (RRT) on patient outcome in intensive
diac and vascular disorders, peripheral vasodilation incare units. This retrospective study compared demographics,
sepsis), postrenal causes (for example, urethral obstruc-severity, course, and prognosis of ARF during 36 months (pe-
riod 1, 1991 through 1993; 128 cases) and 18 months (period tion), or intrarenal causes (for example, ischemic or
2, 1994 through 1995; 141 cases). Compared with period 1, nephrotoxic disorders) lead to the life-threatening com-
during period 2 there was a markedly increased incidence of
plication of ARF.ARF. There were no significant differences in patient demo-
graphics or etiology of renal failure, but the therapeutic ap-
proach to ARF was quite different. During period 2, RRT
METHODSwas started at earlier stages of renal insufficiency (that is, less
elevated creatinine serum concentrations or reduced diuresis). We retrospectively investigated two groups of patients
Additionally, there was a significant increase in the numbers with ARF treated with renal replacement therapy (RRT)of continuous RRT (CRRT) replacing the discontinuous mode
at our university hospital. The first group included allof dialysis treatment. Compared with period 1, mortality was
patients demanding RRT from 1991 through 1993 (36reduced from 78.9 to 59.6% during period 2 (P , 0.001). There
were no differences in mortality between the patients from months), and the second group consisted of all patients
internal and surgical wards. Mortality in patients treated with needing RRT during a period of 18 months in 1994 and
CRRT was in period 1 and in period 2 higher than mortality
1995. All patients were treated by nephrologists at inter-in patients treated with intermittent RRT, but these results
nal or surgical wards and at various intensive care units.are biased by a preferred use of CRRT in severely ill patients
with an unstable circulatory system. These data suggest that Demographic data of the patients, clinical and paraclini-
the early onset of RRT reduces the mortality of intensive care cal parameters, and the method of RRT were compared.
unit patients with ARF independent of underlying diseases. The outcome was investigated only with respect to sur-
An influence of the method of RRT, sex, and age on outcome
vival or death. Data evaluation was performed by statisti-of patients with ARF could not be proven.
cal tests (chi-square test, Mann–Whitney U-test, t-test).
Acute renal failure (ARF) is a severe complication RESULTS
in intensive care patients that is associated with a high
During the period from 1991 to 1993 [6], there was a
mortality and enormous treatment expenditures. The
need for RRT in 128 ARF patients (86 men and 42incidence of ARF is 2 to 5% in patients located in both
women), and during 1994 and 1995 [7], RRT had to besurgical and internal wards and up to 15 to 20% in pa-
applied in 141 ARF patients (88 men and 53 women).tients at intensive care units [1, 2]. ARF is not a symptom
This means a nearly doubled incidence of ARF in 1994of mere renal failure but is an essential part of the
and 1995. Sex distribution in both groups was compara-multiorgan damage syndrome (MODS), which is associ-
ble, and there were no differences in the mean age ofated with poor survival rates, depending on the severity
the patients (1991 through 1993, 58.1 6 1.3 years, 1994of the underlying disease(s) [3, 4]. Uremia itself is only
and 1995, 60.9 6 1.2 years). Moreover, there were no
relevant differences in the occurrence of ARF in internal
medicine and surgery (Table 1).Key words: continuous renal replacement therapy, mortality and
CRRT, intermittent renal replacement therapy, acute renal failure. The severity of underlying disease(s), documented by
the need of catecholamines and artificial respiration, was 1999 by the International Society of Nephrology
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Table 1. Frequency of acute renal failure (ARF) in internal
medicine and surgery
Internal medicine % Surgery %
Oncology (N520) 26.1 Cardiosurgery (N563) 39.9
Gastroenterology (N530) 27.1 Vascular surgery (N529) 18.4
Cardiology (N531) 27.9 Abdominal surgery (N530) 18.9
Others (N521) 18.9 Cancer surgery (N520) 12.7
Traumatology (N516) 10.1
Fig. 3. Severity of the underlying disease in ARF patients treated with
intermittent renal replacement therapy (IRRT) in (j) 1991–1993 and
(h) 1994–1995. Abbreviations are: Art. resp., artificial respiration; Ca-
tech 1, need of catecholamines.
Fig. 1. Severity of the underlying disease in patients with acute renal
failure (ARF). The two study periods were (j) 1991–1993, and (h)
1994–1995. Abbreviations are: Catech 1, need of catecholamines; Ca-
tech –, no need of catecholamines; Art. resp., artificial respiration;
Spont. resp., spontaneous respiration.
Fig. 4. Distribution of mortality in ARF patients who were treated
in internal medicine units and surgical wards in 1991–1993 (j) and
1994–1995 (h).
in general. Furthermore, the decision to use CRRT was
biased by an improvement of technical equipment for
CRRT during that time, which made a higher number
of CRRT treatments possible.
In 1994 and 1995, the mortality of ARF patients was
58.6%, which was significantly lower (P , 0.001) thanFig. 2. Severity of the underlying disease in ARF patients treated with
in 1991 through 1993, when it was 79.8%. The samecontinuous renal replacement therapy (CRRT). The two study periods
were (j) 1991–1993, and (h) 1994–1995. Abbreviations are: Art. resp., distribution was found after designating the patients into
artificial respiration; Catech. 1, need of catecholamines. internal and surgical groups (Fig. 4). Furthermore, in
both periods, there were no significant differences in
mortality between internal and surgical patients. An in-
fluence of sex and age on the outcome of patients withnot significantly different in both groups (Fig. 1), but
there were remarkable differences in patients treated ARF could not be proved.
If we say that the severity of underlying disease iswith continuous RRT (CRRT) and intermittent RRT
(IRRT), respectively (Figs. 2 and 3). The reason that the the relevant factor for prognosis of ARF, we have to
postulate a correlation between the mortality and sever-rate of severely ill patients treated with IRRT in 1991
through 1993 was higher than in 1994 and 1995 is a more ity of the underlying disease. Also, we indeed found a
significantly (P , 0.05) higher mortality in severely illconsequent approach to the indication of CRRT in these
patients, which also led to a higher percentage of CRRT patients than in patients without the need of catechola-
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Fig. 5. Mortality of ARF is dependent upon the severity of the underly-
Fig. 7. Mortality of ARF is dependent upon the renal replacementing disease in the (j) 1991–1993 and (h) 1994–1995 study periods.
method in the (j) 1991–1993 and ( ) 1994–1995 study periods.Abbreviations are: Catech 1, need of catecholamines; Catech 2, no
catecholamines; Art. resp., artificial respiration; Spont. resp., spontane-
ous respiration.
if three or four catecholamines are needed (Fig. 7). The
question is this: What is the reason for the lower mortal-
ity of ARF in 1994 and 1995? We found out that both
in internal and in surgical patients, the creatinine levels
before starting RRT in 1994 and 1995 were significantly
lower (P , 0.001) than in 1991 through 1993 and that
there were higher urine volumes at this time (Fig. 8).
DISCUSSION
The mortality of internal and surgical ARF patients
was significantly lower (P , 0.001) in 1994 and 1995 than
in 1991 through 1993. In patients with extremely severe
underlying disease (defined by need of catecholamines
and artificial respiration), mortality could not be de-
creased significantly. At the first glance, it seems as if
there is a higher survival rate in patients treated with
IRRT than in patients who were on CRRT. However,Fig. 6. Mortality and the need for catecholamine therapy. Data are
this result is biased by the severity of the underlyingfrom the 1991–1993 period as a similar distribution but lower mortality
rates were found during the 1994–1995 period. Symbols are (h) 0 disease, which strongly influences final outcome. Patients
catecholamines; ( ) 1 to 2 catecholamines; (j) 3 to 4 catecholamines.
who were severely ill and therefore in unstable condi-
tions (heart failure, septicemia, and so forth) could only
be treated with CRRT, whereas patients in more stable
conditions could be treated with IRRT [8–12]. There-mines and artificial respiration. Moreover, there were
fore, in our investigation, an influence of the method ofno differences in mortality of severely ill patients be-
RRT on the outcome of patients with ARF could nottween 1991 and 1993 and 1994 and 1995. Only the mortal-
be proven.ity of the less severely ill patients was significantly re-
In 1994 and 1995, RRT was commenced at markedlyduced (P , 0.01) in 1994 and 1995 (Fig. 5).
earlier stages of ARF than in 1991 through 1993, as itDepending on the RRT method, we found a signifi-
is indicated by significantly lower (P , 0.001) creatininecantly (P , 0.05) higher mortality of patients treated
levels and less reduced diuresis. However, only thosewith CRRT than in patients treated with IRRT and a
patients who suffered from less severe underlying dis-significantly (P , 0.001) lower mortality in patients
eases seem to gain benefit from this management. Oncetreated with IRRT (Fig. 6), but the latter was true in
more, this indicates that the severity of underlying dis-1994 and 1995 only.
ease and concomitant organ failures are most relevantThe important influence of the severity of the underly-
limiting factors for the prognosis of ARF [13–15].ing disease on the mortality of ARF is documented once
Nevertheless, early commencement of RRT largelymore by an increase of mortality depending on the need
of catecholamines. Mortality increases up to nearly 100% resolves azotemia/uremia and its harmful sequels, and
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Fig. 8. Laboratory parameters before start-
ing renal replacement therapy in the (j)
1991–1993 and ( ) 1994–1995 study periods.
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